// App-Quantinova.ai

TPS3099 : A Phase 1 study of MEDI1873 in adult patients with select advanced solid tumors.

Researchers

Presenter

  • Ani Sarkis Balmanoukian

Principal Investigators

  • Scott Joseph Antonia

  • Ross A. Stewart

  • Chelsea Black

  • Fujun Wang

  • Joyce Antal

  • Joyson Joseph Karakunnel

  • Jeffrey R. Infante

Medical Centers

  • The Angeles Clinic and Research Institute, Los Angeles, CA

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • MedImmune, Cambridge, United Kingdom

  • MedImmune, Gaithersburg, MD

  • Sarah Cannon Research Institute, Nashville, TN

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Immunol

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Pharmacodynamics

  • Open Label

  • Multicenteric

  • Dose Escalation

  • First-In-Human

Phase

  • I

Study Id's

  • NCT02583165

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved